NASDAQ:ADXS - Advaxis News Headlines

Sign in or create an account to add this stock to your watchlist.
$0.48 -0.01 (-2.04 %)
(As of 03/22/2019 04:00 PM ET)
Previous Close$0.48
Today's Range$0.4430 - $0.50
52-Week Range$0.18 - $2.04
Volume2.05 million shs
Average Volume2.09 million shs
Market Capitalization$33.48 million
P/E Ratio-0.37
Dividend YieldN/A
Beta3.94

Headlines

Advaxis (NASDAQ ADXS) News Headlines

Source:
DateHeadline
Has Advaxis (ADXS) Outpaced Other Medical Stocks This Year? - NasdaqHas Advaxis (ADXS) Outpaced Other Medical Stocks This Year? - Nasdaq
www.nasdaq.com - March 23 at 11:50 AM
Key events next week - healthcare (part 2) - Seeking AlphaKey events next week - healthcare (part 2) - Seeking Alpha
seekingalpha.com - March 22 at 11:11 AM
Has Advaxis (ADXS) Outpaced Other Medical Stocks This Year?Has Advaxis (ADXS) Outpaced Other Medical Stocks This Year?
finance.yahoo.com - March 22 at 11:11 AM
These Four Healthcare Stocks Are Making Moves on WednesdayThese Four Healthcare Stocks Are Making Moves on Wednesday
finance.yahoo.com - March 13 at 4:55 PM
Advaxis (ADXS) Posts Quarterly  Earnings Results, Beats Estimates By $0.43 EPSAdvaxis (ADXS) Posts Quarterly Earnings Results, Beats Estimates By $0.43 EPS
www.americanbankingnews.com - March 13 at 10:38 AM
Seres Therapeutics (MCRB) in Focus: Stock Moves 6.7% HigherSeres Therapeutics (MCRB) in Focus: Stock Moves 6.7% Higher
finance.yahoo.com - March 13 at 10:04 AM
Advaxis, Inc. (ADXS)Advaxis, Inc. (ADXS)
finance.yahoo.com - March 12 at 12:53 PM
Advaxis Reports First Quarter Fiscal 2019 Financial Results and Provides Clinical Pipeline UpdateAdvaxis Reports First Quarter Fiscal 2019 Financial Results and Provides Clinical Pipeline Update
finance.yahoo.com - March 12 at 12:53 PM
Advaxis: Fiscal 1Q Earnings SnapshotAdvaxis: Fiscal 1Q Earnings Snapshot
finance.yahoo.com - March 12 at 12:53 PM
Advaxis Announces Presentations of ADXS-NEO and ADXS-PSA Data at Upcoming American Association for Cancer Research Annual MeetingAdvaxis Announces Presentations of ADXS-NEO and ADXS-PSA Data at Upcoming American Association for Cancer Research Annual Meeting
www.marketwatch.com - March 11 at 8:06 AM
Reviewing Clearside Biomedical (CLSD) & Advaxis (ADXS)Reviewing Clearside Biomedical (CLSD) & Advaxis (ADXS)
www.americanbankingnews.com - March 10 at 8:05 PM
Advaxis (ADXS) Upgraded to Buy: Here's What You Should KnowAdvaxis (ADXS) Upgraded to Buy: Here's What You Should Know
finance.yahoo.com - February 20 at 4:58 PM
Advaxis (ADXS) Upgraded to Buy: Heres What You Should KnowAdvaxis (ADXS) Upgraded to Buy: Here's What You Should Know
www.zacks.com - February 20 at 11:25 AM
Enrollment underway in study of Advaxis candidate for NSCLC; shares up 6%Enrollment underway in study of Advaxis candidate for NSCLC; shares up 6%
seekingalpha.com - February 14 at 4:52 PM
Advaxis Announces Enrollment of the First Patient in its Phase 1/2 Trial for ADXS-HOT in the Treatment of Non-Small Cell Lung CancerAdvaxis Announces Enrollment of the First Patient in its Phase 1/2 Trial for ADXS-HOT in the Treatment of Non-Small Cell Lung Cancer
finance.yahoo.com - February 14 at 10:37 AM
How Financially Strong Is Advaxis, Inc. (NASDAQ:ADXS)?How Financially Strong Is Advaxis, Inc. (NASDAQ:ADXS)?
finance.yahoo.com - February 12 at 4:40 PM
Advaxis Presents an Overview of its Lm Platform and Neoantigen-Directed Programs at the Immuno-Oncology 360° ConferenceAdvaxis Presents an Overview of its Lm Platform and Neoantigen-Directed Programs at the Immuno-Oncology 360° Conference
finance.yahoo.com - February 6 at 10:28 AM
Advaxis to Present an Overview of its Lm Platform and New Information on its Neoantigen-Directed Therapy Programs at the Immuno-Oncology 360° Conference - Business WireAdvaxis to Present an Overview of its Lm Platform and New Information on its Neoantigen-Directed Therapy Programs at the Immuno-Oncology 360° Conference - Business Wire
www.businesswire.com - January 30 at 4:42 PM
Advaxis to Present an Overview of its Lm Platform and New Information on its Neoantigen-Directed Therapy Programs at the Immuno-Oncology 360° ConferenceAdvaxis to Present an Overview of its Lm Platform and New Information on its Neoantigen-Directed Therapy Programs at the Immuno-Oncology 360° Conference
finance.yahoo.com - January 28 at 10:32 AM
Data Highlighting Potential Benefits of Lm Platform Presented at 2019 Keystone Symposia Conference on Cancer VaccinesData Highlighting Potential Benefits of Lm Platform Presented at 2019 Keystone Symposia Conference on Cancer Vaccines
finance.yahoo.com - January 25 at 10:01 AM
FDA halts recruitment in Advaxis late-stage study of AXAL in cervical cancerFDA halts recruitment in Advaxis late-stage study of AXAL in cervical cancer
seekingalpha.com - January 23 at 4:45 PM
Advaxis’ Phase 3 AIM2CERV Study Placed on Partial Clinical Hold by FDA Related to CMC RequestsAdvaxis’ Phase 3 AIM2CERV Study Placed on Partial Clinical Hold by FDA Related to CMC Requests
finance.yahoo.com - January 23 at 4:45 PM
Advaxis Inc. (ADXS) CEO Ken Berlin on Q4 2018 Results - Earnings Call Transcript - Seeking AlphaAdvaxis Inc. (ADXS) CEO Ken Berlin on Q4 2018 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - January 16 at 10:01 AM
Edited Transcript of ADXS earnings conference call or presentation 15-Jan-19 4:00pm GMTEdited Transcript of ADXS earnings conference call or presentation 15-Jan-19 4:00pm GMT
finance.yahoo.com - January 16 at 10:01 AM
The Daily Biotech Pulse: Agile Gives Regulatory Update On Contraceptive Patch, Advaxis Misses Estimates, Ocular Submits sNDAThe Daily Biotech Pulse: Agile Gives Regulatory Update On Contraceptive Patch, Advaxis Misses Estimates, Ocular Submits sNDA
finance.yahoo.com - January 11 at 5:28 PM
Advaxis (ADXS) Reports Q4 Loss, Tops Revenue EstimatesAdvaxis (ADXS) Reports Q4 Loss, Tops Revenue Estimates
finance.yahoo.com - January 11 at 10:13 AM
Advaxis net loss for fiscal 2018 ($66.5M)Advaxis net loss for fiscal 2018 ($66.5M)
seekingalpha.com - January 10 at 4:55 PM
Advaxis misses by $0.19, misses on revenueAdvaxis misses by $0.19, misses on revenue
seekingalpha.com - January 10 at 4:55 PM
Advaxis Reports Fiscal Year 2018 Financial Results and Provides a Business UpdateAdvaxis Reports Fiscal Year 2018 Financial Results and Provides a Business Update
finance.yahoo.com - January 10 at 4:55 PM
Advaxis to Host Business Update Conference Call on January 15, 2019Advaxis to Host Business Update Conference Call on January 15, 2019
finance.yahoo.com - January 8 at 9:38 AM
Form SC 13G/A Advaxis, Inc. Filed by: AMGEN INC - StreetInsider.comForm SC 13G/A Advaxis, Inc. Filed by: AMGEN INC - StreetInsider.com
www.streetinsider.com - December 29 at 4:43 PM
Form PRE 14A Advaxis, Inc. For: Dec 28 - StreetInsider.comForm PRE 14A Advaxis, Inc. For: Dec 28 - StreetInsider.com
www.streetinsider.com - December 29 at 4:43 PM
When Larger Firms Walk Away From Partnerships With Smaller Ones: How Bad Is The Damage?When Larger Firms Walk Away From Partnerships With Smaller Ones: How Bad Is The Damage?
www.benzinga.com - December 21 at 4:45 PM
Advaxis (ADXS) PT Lowered to $3 at Euro Pacific CapitalAdvaxis (ADXS) PT Lowered to $3 at Euro Pacific Capital
www.streetinsider.com - December 18 at 9:42 AM
Advaxis down 36% on Amgen exit from ADXS-NEO programAdvaxis down 36% on Amgen exit from ADXS-NEO program
seekingalpha.com - December 14 at 4:35 PM
Could Advaxis, Inc.’s (NASDAQ:ADXS) Investor Composition Influence The Stock Price?Could Advaxis, Inc.’s (NASDAQ:ADXS) Investor Composition Influence The Stock Price?
finance.yahoo.com - December 12 at 5:05 PM
Will Advaxis (ADXS) Report Negative Earnings Next Week? What You Should KnowWill Advaxis (ADXS) Report Negative Earnings Next Week? What You Should Know
finance.yahoo.com - December 12 at 5:05 PM
Advaxis to Present at LD Micro Main EventAdvaxis to Present at LD Micro Main Event
finance.yahoo.com - November 28 at 9:33 AM
Advaxis to Present Poster Entitled “Natural Killer (NK) Cells Orchestrate the Antitumor Activities of Listeria monocytogenes (Lm)-Based Immunotherapy” at Society for Immunotherapy of Cancer Annual MeetingAdvaxis to Present Poster Entitled “Natural Killer (NK) Cells Orchestrate the Antitumor Activities of Listeria monocytogenes (Lm)-Based Immunotherapy” at Society for Immunotherapy of Cancer Annual Meeting
finance.yahoo.com - November 6 at 9:06 AM
Advaxis, RevisitedAdvaxis, Revisited
seekingalpha.com - November 5 at 4:47 PM
Advaxis (ADXS) CEO Ken Berlin on Q3 2018 Results - Earnings Call TranscriptAdvaxis' (ADXS) CEO Ken Berlin on Q3 2018 Results - Earnings Call Transcript
seekingalpha.com - November 3 at 9:19 AM
Advaxis bails on Phase 1/2 study of AXAL + Imfinzi; may tweak design of Phase 3 trial of AXAL monotherapy to accelerate data readout; shares down 6% premarketAdvaxis bails on Phase 1/2 study of AXAL + Imfinzi; may tweak design of Phase 3 trial of AXAL monotherapy to accelerate data readout; shares down 6% premarket
seekingalpha.com - November 2 at 4:43 PM
Advaxis (ADXS) Announces Update on Clinical PipelineAdvaxis (ADXS) Announces Update on Clinical Pipeline
www.streetinsider.com - November 2 at 4:43 PM
Advaxis Provides Update on Clinical PipelineAdvaxis Provides Update on Clinical Pipeline
finance.yahoo.com - November 2 at 9:57 AM
Advaxis to Host Business Update Conference Call on November 2, 2018Advaxis to Host Business Update Conference Call on November 2, 2018
finance.yahoo.com - October 26 at 9:17 AM
Investor Expectations to Drive Momentum within Aethlon Medical, Jaguar Animal Health, Advaxis, Forestar Group ...Investor Expectations to Drive Momentum within Aethlon Medical, Jaguar Animal Health, Advaxis, Forestar Group ...
globenewswire.com - October 19 at 9:12 AM
Advaxis to Present at the Cantor Fitzgerald Global Healthcare ConferenceAdvaxis to Present at the Cantor Fitzgerald Global Healthcare Conference
finance.yahoo.com - September 25 at 8:45 AM
Advaxis Inc (NASDAQ:ADXS): How Much Growth Is Left In Healthcare?Advaxis Inc (NASDAQ:ADXS): How Much Growth Is Left In Healthcare?
finance.yahoo.com - September 11 at 4:43 PM
Advaxis: Fiscal 3Q Earnings SnapshotAdvaxis: Fiscal 3Q Earnings Snapshot
finance.yahoo.com - September 11 at 9:08 AM
Advaxis Reports Fiscal 2018 Third Quarter Business Highlights and Financial ResultsAdvaxis Reports Fiscal 2018 Third Quarter Business Highlights and Financial Results
finance.yahoo.com - September 10 at 4:36 PM
This page was last updated on 3/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel